Related Experiment Videos
Severe mycoplasma pneumonia in young children with Down syndrome
S L Orlicek1, M S Walker, T L Kuhls
1Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City.
Insights
Young children with Down syndrome may experience severe mycoplasma pneumonia due to immune issues. Physicians should consider Mycoplasma pneumoniae in Down syndrome patients presenting with pneumonia symptoms.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Down syndrome is associated with immune abnormalities, potentially increasing susceptibility to infections.
- Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in children.
Observation:
- Three young children with Down syndrome presented with symptoms including fever, cough, wheezing, irritability, and tachypnea.
- Chest radiographs revealed bilateral infiltrates, and all children developed respiratory distress requiring hospitalization.
Findings:
- Laboratory studies indicated Mycoplasma pneumoniae as the likely cause of pneumonia in these children.
- The severity of infection may be linked to immune dysregulation in Down syndrome.
Implications:
- This case series suggests Mycoplasma pneumoniae should be considered in the differential diagnosis of pneumonia in young children with Down syndrome.
- Early consideration of this pathogen may lead to timely diagnosis and appropriate management, potentially preventing severe outcomes.
Abstract:
Three young children with Down syndrome developed fever, cough, wheezing, irritability, and tachypnea. They had bilateral infiltrates on their chest radiographs and developed respiratory distress, which required their hospitalization. Laboratory studies suggested that the children had mycoplasma pneumonia. These children may have experienced severe mycoplasma infections early in life because of their Down syndrome-associated immune abnormalities. When young children with Down syndrome develop pneumonia, physicians should consider Mycoplasma pneumoniae as the possible etiologic agent.